SMI Event:::: COPD 19th & 20th Oct 2015

 


19th & 20th Oct 2015
Holiday Inn Regents Park, London UK
www.copd-conference.co.uk
Sponsored by Quintiles
 

 

3HRS + OF VALUABLE NETWORKING

18 THOUGHT PROVOKING PRESENTATIONS + 1 EXCLUSIVE QUINTILES WORKSHOP
SPEAKERS INCLUDE NOVARTIS, VERONA, MUNDIPHARMA, JANSSEN, MEDIMMUNE, CHIESI
NOW RUNNING FOR ALMOST A DECADE – 7 YEARS OF COPD EXPERTISE


Now in its 7th year, COPD 2015 will look to provide the industry with a niche platform for discussion and a forum to learn from market led case studies and key note addresses delivered through five compelling sessions.

Scope of conference

SESSION 1.    DRUG DEVELOPMENT AND COMBINATIONAL THERAPIES :

Gain insight into formulation developments and the manufacturing of dry powder inhalation products through a keynote address delivered by Novartis’s Operational Lead in Inhalation and New Solids, Dr Frank Thielmann. The role of immunology, protein kinase pathways and novel therapeutic agents will also be discussed by Imperial College London, the National Heart & Lung Institute and the University of Basque respectively. Strategic guidance on combination therapy will be given by Teva and Prosonix, plus Verona Pharma CEO, Jan Anders-Karlsson, provides an exclusive address on their “first in class” inhaled COPD Drug.

SESSION 2.   DEVELOPING CLINICAL TRIALS FOR COPD :

Novartis COPD Medical Director, Dr Konstantinos Kostikas ascertains the ACOS Definition and explains the characteristics of a grey-zone syndrome which is currently excluded from asthma and COPD trials. In this session, key topics on endpoint in clinical trials, patient selection, recruitment and effective rehabilitation will also be covered by Mundipharma, University hospital Geneva and Respiratory Research Clinical Trials.

SESSION 3.    DEFINING COPD PULMONARY INDICATIONS THROUGH BIOMARKERS :

Glyconics Limited open the session with an update on hand held device for biomarker selection which uses ground breaking technology in respiratory clinical diagnostics. This will be followed by a Janssen case study on the ADEPT Trial which will discuss personalised medicine and biomarker assessment.

SESSION 4.    COPD CO-MORBIDITIES :

This spotlight will ask questions such as: What is this link between co-morbidities and disease? What current issues do co-morbidities present with COPD treatment? Do corticosteroids cause more harm than good?

SESSION 5.    MANAGING EXACERBATIONS :

An update on the clinical management of exacerbations will be given by  Chiesi Chief Medical Officer and Director of Global Clinical Development, Stefano Petruzzelli. With additional presentations from University Hospital Genevaand MedImmune, the final session will address pulmonary rehabilitation, non-invasive ventilation and will investigate the role if ectopic lymphoid follicles in respiratory disease.

Closing remarks:

The conference closes with a host nation addresses presented by the British Lung Foundation. Noell Snell, Director of Research, evaluates the current state of UK respiratory research, its future outlook, and its strategy in partnership with patients.

Download a brochure before registering HERE or make an enquiry

How to register:

Register your place online at www.copd-conference.co.uk

For bespoke sponsorship packages contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk

For delegate enquires, contact Tommy King on +44 (0)20 7827 6052 or email tking@smi-online.co.uk

SMI EVENT::::::Biosimilars and Biobetters (30th September – 1st October 2015)

231x231-Biosimilars-and-BiobettersDESCRIPTION:  SMi’s 6th annual Biosimilars and Biobetters conference, taking place on 30th September – 1st October 2015 in London, will detail product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing & reimbursement through to emerging markets and global development with case study driven presentations from companies including GfK, Teva, Harvest Moon Pharmaceuticals USA Inc and many more, as they present on the latest development on key topics including regulatory landscape, pharmacovigilance of biosimilars, patent litigation, market access and EU & global market developments. For further information and to register, visit http://www.biosimilars-biobetters.co.uk/benthamscience

Biosimilars and Biobetters – 30 September – 1 October 2015
Holiday Inn Kensington Forum, London UK
URL: http://www.biosimilars-biobetters.co.uk/benthamscience

ADC Summit 18-19 May 2015, London, UK

200-x-200SMi is delighted to announce that its 4th annual ADC Summit 2015 conference will take place on 18th – 19th May in London, UK.

Recent clinical successes have generated intense interest in antibody-drug conjugates and they are now an increasingly active area of biopharma research, with developers and manufacturers investing towards this revolutionary therapeutic. To develop ADCs that are more specific, more stable, and more effective; continued optimisation of the antibody, linker and payload of an ADC is critical.

This conference goes to the heart of the technological challenges and asks: What does it take to develop superior ADCs and gain the clinical edge? It will share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

BENEFITS OF ATTENDING:

• Hear more about the payload developments
• Receive updates on ADCs in clinical trials
• Learn more about biodistribution and tumour penetrations
• Aim for improvement of the therapeutic index
• Discover strategies for effective targeting ADC off-target toxicities
• Understand the status of the development of novel binding moieties

KEY SPEAKERS INCLUDE:

– Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.
– David Thurston, Professor of Drug Discovery, King’s College London
– Angela Romanelli, Senior Director, Biomarkers, ImmunoGen, Inc.
– Christophe Bonny, Chief Scientific Officer, Bicycle Therapeutics Limited
– Klaus Bosslet, Head Discovery Oncology, Pharma Research & Early Development, Roche Innovation Center Penzberg
– Iontcho Vlahov, Vice President of Discovery Chemistry, Endocyte, Inc.
– Vijay Chudasama, Research Associate, University College London

In addition, don’t miss the interactive half-day post-conference workshop taking place on the 20th May 2015, Holiday Inn Bloomsbury, London, UK entitled: ADCs: A Journey Through Development
Workshop Leaders: Dr. Richard Turner, Principle Consultant, Natalie Thomas, Consultant, Simon Bishop, Associate Consultant at BioDesk

Book by February 27th to benefit from the £300 early bird discount.

http://www.smi-online.co.uk/2015conjugates7.asp

SMI Event::::Controlled Release Conference

Controlled Release Conference

P-132-200-x-20020th & 21st April 2015,

Marriott Hotel Regents Park, London, UK

www.smi-online.co.uk/2015controlledrelease28.asp

Following on from our previous events, SMi’s is proud to present their Controlled Release Conference taking place on 20th & 21st April 2015. This two day forum is set to bring together key industry leaders from big pharma companies, biotech companies and academia discussing ground breaking topics looking at advances made in the field of research in the treatment of diseases and how to overcome the challenges involved when developing controlled release formulations. This is a must attend event if you want to be at the fore front of the latest research and development as well as networking with industry innovators who are leading the way on current activities and trends in this arena.

Visit the website: www.smi-online.co.uk/2015controlledrelease28.asp

For further details contact Kinga Gradalska on +44 (0)20 7827 6192 or email: kgradalska@smi-online.co.uk

 

 

SMI Event::::Asthma & COPD

Asthma & COPD

200x200 asthma

13TH APRIL – 14TH APRIL 2015

Holiday Inn Regents Park Hotel, London UK

http://www.smi-online.co.uk/goto/2015asthma-copd16.asp

Description:
Set to take place on 13th and 14th April, SMI’s sell-out Asthma & COPD conference returns to London next spring for its 11th annual show. With the global market for asthma and COPD drugs set to reach $41.23bn in 2017, Asthma & COPD 2015 comes at the perfect time to explore the future of therapeutics, diagnosis and care. We have worked closely with a leading panel of experts such as Genentech, GSK, MedImmune, Amgen and Imperial College of London, to create an agenda that will provide unique insights into topics such as lab to clinic pathways, personalised care, viruses in asthma and COPD, future advancements, PLUS MUCH MORE

To register or for further information, visit http://www.smi-online.co.uk/goto/2015asthma-copd16.asp
Alternatively contact the team on +44 (0)870 9090 712 or email events@smi-online.co.uk

SMI Event::::Paediatric Clinical Trials

Paediatric Clinical Trials

200X200

25TH MARCH – 26TH MARCH 2015

Holiday Inn Regents Park Hotel, London UK

http://www.smi-online.co.uk/goto/2015paediatric-trials24.asp

Description:
Returning for its 9th year, SMi are proud to present the industry leading event on Paediatric Clinical Trials, taking place on 25th and 26th March 2015 in Central London. Join us as we ask questions such as: What procedures can we follow to limit the number of PIP modifications required? Optimizing patient retention strategies for successful trial development – how do we keep patients on board? How do you apply physiologically based pharmacokinetic modelling to select starting doses in children? We have worked with an expert panel of speakers such as the MHRA, Paediatric Committee, Novo Nordisk and GSK, to bring to you a packed agenda addressing key topics such as Paediatric Investigation Plan (PIP) strategies, the challenges of a limited patient population, site selection, patient retention, PLUS MUCH MORE!

To register or for further information,
visit http://www.smi-online.co.uk/goto/2015paediatric-trials24.asp

Alternatively contact the team on +44 (0)870 9090 712
or email events@smi-online.co.uk

SMI Event: Cancer Vaccines

15TH SEPT – 16TH SEPTEMBER 2014

Holiday Inn Regents Park, London UK

http://www.smi-online.co.uk/goto/2014cancervaccinesevent18.asp

Cancer Vaccines 2014 provides a unique opportunity for professionals to gather as a community and learn about the latest in developments in Cancer Vaccines. Hear keynotes from University Pennsylvania, Amgen, Immatics, DanDrit Biotech, Immunicum, CureVac plus many more. For further details visit http://www.smi-online.co.uk/goto/2014cancervaccinesevent18.asp

Image

SMI Event: Immunogenecity

SMI Event: Immunogenecity

SMI Events: ALLERGIES

ImageALLERGIES:

9TH – 10 JULY 2014

Holiday Inn Regents Park, London UK

http://www.smi-online.co.uk/goto/allergies7.asp

 

Description:

SMi Group Ltd have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together an exciting conference agenda for the inaugural Allergies conference taking place on 9th July and 10th July 2014 in Central London . For further details visit http://www.smi-online.co.uk/goto/allergies7.asp

 

SMI Events: ADMET

ImageADMET:

30TH JUNE – 1ST JULY 2014

The Marriott Regents Park Hotel, London UK

http://www.smi-online.co.uk/goto/2014admet19.asp

 Description:

SMi are proud to present their 9th annual ADMET Conference to be held from the 30th June and 1st July 2014 in Central London. With a focus on enhancing drug quality by ADMET optimisation in discovery, this year’s event will feature over eighteen industry led presentations discussing admet in drug development, biologicals versus small molecules, predictive value of toxicity, in silico and in vitro approaches, drug transporters plus much more. For further details visit http://www.smi-online.co.uk/goto/2014admet19.asp

 

%d bloggers like this: